Building Hope – The Michael J. Fox Foundation

A researcher at the City College of New York fills test tubes in the College’s lab. She is among the recipients of the more than $275 million in Parkinson’s research funding that the Foundation has awarded to date.

Thomson Reuters 09 Apr 2012Thomson Reuters

At Thomson Reuters we’re dedicated to serving the world’s builders — our customers — by building the tools they rely on to lay the foundation for innovation, scientific discovery, efficient and transparent markets, and effective navigation of legal, regulatory and tax environments. Our 2011 Annual Report highlights the work of five builders. Here is one of those stories:

At The Michael J. Fox Foundation in New York, Brian Fiske heads a research team working to uncover new insights into Parkinson’s disease. The degenerative neurological disorder strikes one in every 100 people over the age of 60. As Parkinson’s has no clear biomarker, geneticists and neuroscientists like Fiske rely on collaborative tools and shared data to further their understanding of the disease. The MetaCore™ database is foundational to exploration of LRRK2—a promising effort in their search for a cure. Fiske and his colleagues are building hope for a future free from Parkinson’s.

To learn more about some of the amazing things the Michael J. Fox Foundation is doing, read the full story and watch the video below: